Effect of acetylcysteine plus simeticone pre‑medication on gastric visibility in patients undergoing upper endoscopy with chromoendoscopy
Prefer not to search on your own, or looking for clinical trials for a rare disease?
What is this trial about?
A plain-language summary of the goals, design and what participants do
The study involves people who are scheduled for an upper gastrointestinal endoscopy, a procedure in which a thin tube with a camera is passed through the mouth to look at the lining of the stomach and esophagus. Before the exam, participants will receive a combination of two medicines: N-acetylcysteine, which helps thin mucus, and simethicone, which reduces gas bubbles. The combination is referred to as GASTROprep and is taken as an oral solution about 30 to 60 minutes before the endoscopy.
The purpose of the study is to find out whether taking this pre‑medication improves how clearly the stomach lining can be seen during the exam. After taking the medicine, participants will go through the standard endoscopy, during which the doctor may clean the area with water if needed and may take small tissue samples, called biopsies, to examine under a microscope. The clarity of the stomach lining will be scored using a simple rating system known as the Barcelona scale, and any extra cleaning steps or side effects will be recorded.
Participants will stay in the clinic for the short time needed for the medication to work and for the endoscopy itself. After the procedure, they will be asked about any discomfort or unusual symptoms, and the medical team will monitor for any adverse reactions. The overall length of the endoscopy, the number of biopsies taken, and the findings will be noted, but no additional visits or special tests are required beyond the routine exam.
The research process
The trial runs in 7 steps – from screening to follow-up. Each step says what happens and what the team monitors.
Who can join the trial?
2 criteria
- Be 18 years old or older and able to understand and sign a consent form (informed consent means agreeing to join after being told what will happen)
- Be an outpatient who has an appointment for an upper gastrointestinal endoscopy (a test where a thin tube with a camera looks at the esophagus, stomach, and the start of the small intestine) with chromoendoscopy (a technique that uses special dyes to make the lining easier to see) at the participating hospital’s endoscopy unit
Who cannot join the trial?
8 criteria
- You must be at least 18 years old; anyone younger cannot join.
- If you are pregnant, you cannot take part in the study.
- If you have a very high risk from anesthesia, called ASA IV (a classification indicating serious health problems that make anesthesia risky), you cannot join.
- If you have had previous gastric surgery that changes the shape or structure of your stomach, you are not eligible.
- If a therapeutic procedure (a treatment planned for you) is already scheduled, you cannot participate.
- If you need a therapeutic endoscopy (an endoscopy that is meant to treat a condition) or an urgent (emergency) procedure, you cannot join.
- If you have an allergy to any part of the medication or a contraindication (a reason why the medication should not be used for you), you cannot take part.
- If you cannot follow the required fasting requirements (not eating or drinking before the test) or cannot take the study medication as instructed, you are not eligible.
Prefer not to search on your own, or looking for clinical trials for a rare disease?
Tell us about your condition – we search every trial in Europe and connect you with the right site.
We usually reply within a few days
Trial locations
Where you can join this trial
Countries are shaded by recruitment status. Click a recruiting country to ask about joining there.
Not yet recruitingNot sure what to do next?
Joining a clinical trial can seem overwhelming. We guide you step by step, so you know exactly what to expect and how we support you through the process.
Investigated drugs
N‑acetylcysteine
is a medication that helps thin and break down thick mucus in the stomach. In this study it is given by mouth a short time before the endoscopy so that the lining of the stomach becomes clearer and easier for the doctor to see. By reducing the amount of mucus, it improves the visibility of any abnormal areas and helps the doctor make a more accurate diagnosis.
Simethicone
is an oral medicine that reduces gas bubbles in the stomach and intestines. When taken before the endoscopy, it helps eliminate tiny pockets of air that can create a hazy view on the camera. This makes the stomach lining look smoother and cleaner, allowing the doctor to examine the tissue more effectively.
What is already known about the treatment
Acetylcysteine
Acetylcysteine is taken by mouth as a powder that is mixed with water to form a liquid or as an effervescent tablet that dissolves in water, creating an oral solution. It is a well‑known drug that is widely used to thin thick mucus in the lungs and to protect the stomach lining, and it has been studied extensively in medical literature. The molecule works by breaking the sticky bonds in mucus and by providing a building block that helps the body make a natural antioxidant. It is classified as a mucolytic and antioxidant agent.
Simethicone
Simethicone is administered orally as a liquid emulsion that is swallowed directly or mixed with a small amount of water. It is an over‑the‑counter medication that has been used for many years to reduce gas and bloating, and its safety and effectiveness are well documented. It works by lowering the surface tension of gas bubbles, allowing them to join together and be expelled more easily. It belongs to the class of anti‑foaming agents.
Investigated diseases
Gastric mucosal lesions
These are abnormal changes in the lining of the stomach that can develop gradually over time. They often begin as inflammation and may progress to thinning of the stomach lining, known as atrophy. Continued irritation can lead to the replacement of normal cells with intestinal-type cells, a process called intestinal metaplasia. If the metaplastic area expands, it can form small growths called gastric adenomas. Over many years, these adenomas can evolve into early-stage gastric cancer if left unchecked.
Esophageal lesions
These refer to abnormal areas in the lining of the esophagus that may appear as red patches, ulcers, or raised growths. They frequently start with chronic irritation from acid reflux, leading to inflammation. Persistent inflammation can cause the cells to change their appearance, a condition known as Barrett’s esophagus. The altered cells may develop into dysplasia, a precancerous state. With ongoing cellular changes, dysplasia can advance to early esophageal cancer.
sourced from the EU Clinical Trials Register and site verification
Want to learn more about this trial or check if you can participate?
